Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
International Phase 2 doxycycline for first-line OAMZL
2012-005702-22Phase 2Active
- Sponsor
- International Extranodal Lymphoma Study Group
- Start
- Feb 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of doxycycline in Ocular adnexal mucosa-associated lymphoid tissue lymphoma (OAML), sponsored by International Extranodal Lymphoma Study Group. Started Feb 2013; status: active.
02
Drugs
doxycycline
03
Conditions
Ocular adnexal mucosa-associated lymphoid tissue lymphoma (OAML)
Beyond the preview
Go deeper on 2012-005702-22.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-005702-22.